Clinical Trial Update: Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) [Phase 2]

View source ↗

Summary

Phase 2 evaluation of VX-548 for lumbosacral radiculopathy has been completed, with the study assessing efficacy and safety in patients with painful radiculopat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbosacral Radiculopathy

Drugs mentioned

• VX-548

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Painful Lumbosacral Radiculopathy | Phase 2 | Status: COMPLETED